141 related articles for article (PubMed ID: 38135816)
21. Multiparametric Magnetic Resonance Imaging Correlates of Isocitrate Dehydrogenase Mutation in WHO high-Grade Astrocytomas.
Sahu A; Patnam NG; Goda JS; Epari S; Sahay A; Mathew R; Choudhari AK; Desai SM; Dasgupta A; Chatterjee A; Pratishad P; Shetty P; Moiyadi AA; Gupta T
J Pers Med; 2022 Dec; 13(1):. PubMed ID: 36675733
[TBL] [Abstract][Full Text] [Related]
22. Perfusion parameters derived from MRI for preoperative prediction of IDH mutation and MGMT promoter methylation status in glioblastomas.
Lu J; Li X; Li H
Magn Reson Imaging; 2021 Nov; 83():189-195. PubMed ID: 34506909
[TBL] [Abstract][Full Text] [Related]
23. Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients.
Hallaert G; Pinson H; Vanhauwaert D; Van den Broecke C; Van Roost D; Boterberg T; Kalala JP
Surg Oncol; 2020 Dec; 35():515-519. PubMed ID: 33152608
[TBL] [Abstract][Full Text] [Related]
24. Prediction of
Park YW; Han K; Ahn SS; Bae S; Choi YS; Chang JH; Kim SH; Kang SG; Lee SK
AJNR Am J Neuroradiol; 2018 Jan; 39(1):37-42. PubMed ID: 29122763
[TBL] [Abstract][Full Text] [Related]
25. Gamma distribution model of diffusion MRI for evaluating the isocitrate dehydrogenase mutation status of glioblastomas.
Takase H; Togao O; Kikuchi K; Hata N; Hatae R; Chikui T; Tokumori K; Kami Y; Kuga D; Sangatsuda Y; Mizoguchi M; Hiwatashi A; Ishigami K
Br J Radiol; 2022 May; 95(1133):20210392. PubMed ID: 35138915
[TBL] [Abstract][Full Text] [Related]
26. Dynamic Contrast-Enhanced T1-Weighted Perfusion Magnetic Resonance Imaging Identifies Glioblastoma Immunohistochemical Biomarkers via Tumoral and Peritumoral Approach: A Pilot Study.
Ozturk K; Soylu E; Tolunay S; Narter S; Hakyemez B
World Neurosurg; 2019 Aug; 128():e195-e208. PubMed ID: 31003026
[TBL] [Abstract][Full Text] [Related]
27. Preoperative Magnetic Resonance Imaging Radiomics for Predicting Early Recurrence of Glioblastoma.
Wang J; Yi X; Fu Y; Pang P; Deng H; Tang H; Han Z; Li H; Nie J; Gong G; Hu Z; Tan Z; Chen BT
Front Oncol; 2021; 11():769188. PubMed ID: 34778086
[TBL] [Abstract][Full Text] [Related]
28. Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.
Bale TA; Jordan JT; Rapalino O; Ramamurthy N; Jessop N; DeWitt JC; Nardi V; Alvarez MM; Frosch M; Batchelor TT; Louis DN; Iafrate AJ; Cahill DP; Lennerz JK
Neuro Oncol; 2019 May; 21(5):596-605. PubMed ID: 30496526
[TBL] [Abstract][Full Text] [Related]
29. A clinical evaluation of cystic features in patients with newly diagnosed glioblastoma with IDH-wildtype.
Kim MJ; Park JS; Jeun SS; Ahn S
Clin Neurol Neurosurg; 2023 May; 228():107708. PubMed ID: 37043844
[TBL] [Abstract][Full Text] [Related]
30. Quantitative susceptibility mapping evaluation of glioma.
Zeng S; Ma H; Xie D; Huang Y; Wang M; Zeng W; Zhu N; Ma Z; Yang Z; Chu J; Zhao J
Eur Radiol; 2023 Oct; 33(10):6636-6647. PubMed ID: 37095360
[TBL] [Abstract][Full Text] [Related]
31. Prognostic and Predictive Value of Integrated Qualitative and Quantitative Magnetic Resonance Imaging Analysis in Glioblastoma.
Verduin M; Primakov S; Compter I; Woodruff HC; van Kuijk SMJ; Ramaekers BLT; te Dorsthorst M; Revenich EGM; ter Laan M; Pegge SAH; Meijer FJA; Beckervordersandforth J; Speel EJ; Kusters B; de Leng WWJ; Anten MM; Broen MPG; Ackermans L; Schijns OEMG; Teernstra O; Hovinga K; Vooijs MA; Tjan-Heijnen VCG; Eekers DBP; Postma AA; Lambin P; Hoeben A
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578746
[TBL] [Abstract][Full Text] [Related]
32. Conventional MRI features can predict the molecular subtype of adult grade 2-3 intracranial diffuse gliomas.
Lasocki A; Buckland ME; Drummond KJ; Wei H; Xie J; Christie M; Neal A; Gaillard F
Neuroradiology; 2022 Dec; 64(12):2295-2305. PubMed ID: 35606654
[TBL] [Abstract][Full Text] [Related]
33. An initial study on the predictive value using multiple MRI characteristics for Ki-67 labeling index in glioma.
Du N; Shu W; Li K; Deng Y; Xu X; Ye Y; Tang F; Mao R; Lin G; Li S; Fang X
J Transl Med; 2023 Feb; 21(1):119. PubMed ID: 36774480
[TBL] [Abstract][Full Text] [Related]
34. Vascular architecture mapping for early detection of glioblastoma recurrence.
Stadlbauer A; Eyüpoglu I; Buchfelder M; Dörfler A; Zimmermann M; Heinz G; Oberndorfer S
Neurosurg Focus; 2019 Dec; 47(6):E14. PubMed ID: 31786560
[TBL] [Abstract][Full Text] [Related]
35. Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI.
Yang X; Hu C; Xing Z; Lin Y; Su Y; Wang X; Cao D
Eur Radiol; 2023 Oct; 33(10):7003-7014. PubMed ID: 37133522
[TBL] [Abstract][Full Text] [Related]
36. Combined texture analysis of dynamic contrast-enhanced MRI with histogram analysis of diffusion kurtosis imaging for predicting IDH mutational status in gliomas.
Pan T; Su CQ; Tang WT; Lin J; Lu SS; Hong XN
Acta Radiol; 2023 Sep; 64(9):2552-2560. PubMed ID: 37331987
[TBL] [Abstract][Full Text] [Related]
37. Glioblastomas with and without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity present morphological and microstructural differences on conventional MR images.
Han Q; Lu Y; Wang D; Li X; Ruan Z; Mei N; Ji X; Geng D; Yin B
Eur Radiol; 2023 Dec; 33(12):9139-9151. PubMed ID: 37495706
[TBL] [Abstract][Full Text] [Related]
38. New prognostic factor telomerase reverse transcriptase promotor mutation presents without MR imaging biomarkers in primary glioblastoma.
Ersoy TF; Keil VC; Hadizadeh DR; Gielen GH; Fimmers R; Waha A; Heidenreich B; Kumar R; Schild HH; Simon M
Neuroradiology; 2017 Dec; 59(12):1223-1231. PubMed ID: 28894890
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the Prognosis of High-Grade gliomas in the View of New Immunohistochemistry Markers and 2016 WHO Classification.
Dolen D; Ahmadov T; Dolas I; Unal TC; Aydoseli A; Ozturk M; Sabanci PA; Aras Y; Bilgic MB; Sencer A
Turk Neurosurg; 2022; 32(3):500-507. PubMed ID: 35615769
[TBL] [Abstract][Full Text] [Related]
40. Oligodendrocyte Transcription Factor 2 as a Potential Prognostic Biomarker of Glioblastoma: Kaplan-Meier Analysis and the Development of a Binary Predictive Model Based on Visually Accessible Rembrandt Image and Magnetic Resonance Imaging Radiomic Features.
Mei N; Lu Y; Yang S; Jiang S; Ruan Z; Wang D; Liu X; Ying Y; Li X; Yin B
J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):650-658. PubMed ID: 37380154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]